Search Results  for '600664.SS'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Harbin Pharmaceutical Group Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

25 Jun 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Harbin Pharmaceutical Group Co Ltd (600664-SH)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

28 Jun 2016 Thomson Reuters Stock Report 11 $25.00

Is Harbin Pharmaceutical Group Co., Ltd. Worth a Higher Bid?

14 Jun 2016 Sadif Analytics Prime 12 $25.00

Wright Investors Service Comprehensive Report for Harbin Pharmaceutical Group Company Limited

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

29 May 2016 Wright Reports 61 $75.00

Harbin Pharmaceutical Group Co., Ltd.: Upgraded to Below Average

12 May 2016 Sadif Analytics Prime 3 $10.00

Thomson Reuters Stock Report - Harbin Pharmaceutical Group Co Ltd (600664-SH)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 May 2016 Thomson Reuters Stock Report 11 $25.00

Will Harbin Pharmaceutical Group Co., Ltd. Deliver Top-Shelf Performance?

15 Mar 2016 Sadif Analytics Prime 12 $25.00

Is Harbin Pharmaceutical Group Co., Ltd. Worth a Higher Bid?

09 Dec 2015 Sadif Analytics Prime 12 $25.00

Harbin Pharmaceutical Group Co., Ltd.: Downgraded to Risky

09 Oct 2015 Sadif Analytics Prime 3 $10.00

Company Snapshot - Harbin Pharmaceutical Group Co

A director at Harbin Pharmaceutical Group Co bought 39,000 shares at 10.250CNY and the significance rating of the trade was 6...

08 Oct 2015 Directors Deals Ltd. 1 $12.00